FDA Inspection 1050123 — Siegfried Hameln GmbH
The FDA completed an inspection of Siegfried Hameln GmbH on April 24, 2018 in Hameln. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 24, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hameln (Germany)